Unlocking innovation potential
Key takeaways
- Innovation in healthcare provides a very compelling use case for Growth Debt and can provide a differentiated exposure to a structurally expanding sector with lower economic cyclicality.
- Driven by demographics, innovation, and sustained public and private investment, healthcare offers durable demand characteristics and a deep opportunity set across various market cycles.
- Risk mitigation in healthcare debt is rooted in selectivity, sponsorship quality, and portfolio diversification. Capital is typically deployed to later-stage companies with meaningful equity backing, long cash runways, diversified product pipelines, and clear regulatory or commercial milestones, reducing reliance on binary outcomes.
- Milestone-driven value creation creates structured lending opportunities with asymmetric outcomes. Healthcare valuations often reprice materially at clinical or regulatory inflection points, allowing lenders to underwrite to identifiable catalysts while maintaining structural protections and downside support.
Authors
Aris Constantinides
Managing Director
Sonia Benhamida
Managing Director
Mat Pearse
Executive Director
